Whether or not GBM patients who display an elevation in IFN/STAT1-mediated gene activation have a heightened resistance to virus-mediated infection and oncolysis remains to be determined, but if this proves to be so, it could form a rational basis for prescreening GBM patients for this therapy. Here, IFNA1 is linked to infection.